Transfer factor — development and research of new pharmaceutical form (Q11224): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: EU contribution (P835): 963,359.8624 euro) |
(Changed an Item: Fixing rounding issue) |
||||||||||||||
| Property / EU contribution | |||||||||||||||
963,359.86 Euro
| |||||||||||||||
| Property / EU contribution: 963,359.86 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / EU contribution: 963,359.86 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / EU contribution: 963,359.86 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
Revision as of 09:36, 22 September 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Transfer factor — development and research of new pharmaceutical form |
Project in Czech Republic financed by DG Regio |
Statements
24,083,996.56 Czech koruna
0 references
43,285,400.0 Czech koruna
0 references
55.64 percent
0 references
16 April 2018
0 references
30 April 2020
0 references
AUMED, a.s.
0 references
49°59'56.22"N, 14°25'3.50"E
0 references
14300
0 references
Předložený projekt řeší problematiku přípravy nové lékové formy specifických imunomodulátorů na bázi transfer faktorů (TF) a metod testování jejich imunobiologického potenciálu a. (Czech)
0 references
The proposed project addresses the preparation of a new pharmaceutical form of specific immunomodulators based on transfer of factors (TF) and methods of testing their immunobiortic potential. (English)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/16_083/0010301
0 references